Patent Assignment
Reel/Frame 054075/0948
Assignment of Assignor's Interest
Recorded: 2020-10-16
Pages: 3
Assignor
BROWN, ADRIAN ST. CLAIR
Executed: 2010-01-15
Assignee
PHARMORPHIX
250 SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 OWE, UNITED KINGDOM
Covered Properties
(2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Application:
16/796,250 →
Publication:
US 2020/0190032
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 16, 2020
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 054075/0026 →
Assignment of Assignor's Interest
Oct 16, 2020
From: BRISTOL-MYERS SQUIBB COMPANY
To: EXELIXIS, INC.
Reel/Frame 054075/0269 →
Assignment of Assignor's Interest
Oct 16, 2020
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 054075/0425 →
Assignment of Assignor's Interest
Oct 16, 2020
From: PHARMORPHIX
To: EXELIXIS, INC.
Reel/Frame 054075/0753 →